Merus N.V. (NASDAQ:MRUS) has been given an average rating of “Hold” by the six analysts that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $30.50.
Several research firms recently issued reports on MRUS. Zacks Investment Research upgraded Merus N.V. from a “sell” rating to a “hold” rating in a report on Wednesday, September 13th. Jefferies Group LLC reiterated a “buy” rating and issued a $31.00 price objective on shares of Merus N.V. in a report on Friday, July 14th. Royal Bank Of Canada began coverage on Merus N.V. in a report on Thursday, September 14th. They issued an “outperform” rating and a $28.00 price objective on the stock. Finally, ValuEngine downgraded Merus N.V. from a “hold” rating to a “sell” rating in a report on Monday, October 2nd.
A number of hedge funds and other institutional investors have recently modified their holdings of MRUS. Wellington Management Group LLP purchased a new stake in Merus N.V. during the 1st quarter worth about $29,841,000. Victory Capital Management Inc. purchased a new stake in Merus N.V. during the 1st quarter worth about $976,000. Iguana Healthcare Management LLC increased its holdings in Merus N.V. by 16.7% during the 1st quarter. Iguana Healthcare Management LLC now owns 175,000 shares of the biotechnology company’s stock worth $4,268,000 after purchasing an additional 25,000 shares during the period. Renaissance Technologies LLC purchased a new stake in Merus N.V. during the 1st quarter worth about $549,000. Finally, Spark Investment Management LLC purchased a new stake in Merus N.V. during the 1st quarter worth about $458,000. Institutional investors own 32.16% of the company’s stock.
Merus N.V. (NASDAQ MRUS) opened at 20.83 on Monday. The stock’s 50 day moving average price is $18.00 and its 200 day moving average price is $18.00. The stock’s market cap is $404.02 million. Merus N.V. has a 52 week low of $13.13 and a 52 week high of $33.63.
TRADEMARK VIOLATION WARNING: “Merus N.V. (MRUS) Receives Average Recommendation of “Hold” from Analysts” was published by BBNS and is the sole property of of BBNS. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://baseballnewssource.com/markets/merus-n-v-mrus-receives-average-recommendation-of-hold-from-analysts/1700360.html.
About Merus N.V.
Receive News & Ratings for Merus N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus N.V. and related companies with our FREE daily email newsletter.